BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 71631)

  • 21. Effects of DA agonist in Huntington disease hyperkinesia.
    Caraceni TA; Girotti F; Giovannini P; Pederzoli M; Parati EA
    Ital J Neurol Sci; 1980 Jun; 1(3):155-61. PubMed ID: 6210644
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bromocriptine therapy in patients with acromegaly: effects on growth hormone, somatomedin A and prolactin.
    Werner S; Hall K; Sjöberg HE
    Acta Endocrinol Suppl (Copenh); 1978; 216():199-206. PubMed ID: 347862
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prolactin control in Huntington's chorea.
    Müller EE; Cocchi D; Mantegazza P; Parati EA; Caraceni T
    Lancet; 1977 Oct; 2(8041):764-5. PubMed ID: 71573
    [No Abstract]   [Full Text] [Related]  

  • 24. [Attempted direct etiological treatment of Huntington's chorea. Case reports].
    Majeron MA; Ambrosoli C; Armocida G; Finavera L; Quisi Q
    Minerva Med; 1980 Apr; 71(16):1213-20. PubMed ID: 6445524
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Circadian periodicity of plasma prolactin in some neurological diseases.
    Ferrari E; Nappi G; Vailati A; Martignoni E; Bossolo PA; Polleri A
    Int J Chronobiol; 1979; 6(4):231-42. PubMed ID: 162341
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bromocriptine in Huntington chorea.
    Kartzinel R; Hunt RD; Calne DB
    Arch Neurol; 1976 Jul; 33(7):517-8. PubMed ID: 132915
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The endocrinology of extrapyramidal system disorders.
    Kirkpatrick B; Tamminga CA
    Endocrinol Metab Clin North Am; 1988 Mar; 17(1):159-72. PubMed ID: 2967753
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impaired prolactin release in Huntington's chorea. Evidence for dopaminergic excess.
    Hayden MR; Vinik AI; Paul M; Beighton P
    Lancet; 1977 Aug; 2(8035):423-6. PubMed ID: 70642
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Growth hormone and somatomedin levels in acromegalics treated with bromocriptine.
    Shalet SM; Price DA; Beardwell CG; Mindel A; MacFarlane IA
    Horm Res; 1980; 12(3):121-9. PubMed ID: 6768666
    [No Abstract]   [Full Text] [Related]  

  • 30. Exaggerated growth hormone response to arginine infusion in Huntington's disease.
    Leopold NA; Podolsky S
    J Clin Endocrinol Metab; 1975 Jul; 41(1):160-3. PubMed ID: 125287
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Huntington's chorea and bromocriptine.
    Albano C; Cocito L
    Arch Neurol; 1979 May; 36(5):322. PubMed ID: 156018
    [No Abstract]   [Full Text] [Related]  

  • 32. Circadian rhythmicity of prolactin secretion in Huntington's chorea.
    Polleri A; Savoldi F; Muratorio A; Masturzo P; Murialdo G; Martignoni E; Nappi G; Iudice A; Murri L
    Life Sci; 1980 May; 26(19):1609-17. PubMed ID: 6446012
    [No Abstract]   [Full Text] [Related]  

  • 33. Role of dopaminergic receptors in the regulation of growth hormone secretion.
    Müller EE; Liuzzi A; Cocchi D; Panerai AE; Oppizzi G; Lacatelli V; Mantegazza P; Silvestrini F; Chiodini PG
    Adv Biochem Psychopharmacol; 1977; 16():127-38. PubMed ID: 142419
    [No Abstract]   [Full Text] [Related]  

  • 34. Pharmacology of Huntington's chorea. Personal experience.
    Caraceni T; Giovannini P; Girotti F; Avanzini G
    Eur Neurol; 1977; 16(1-6):42-50. PubMed ID: 150332
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Growth hormone hyperresponsiveness to dopaminergic stimulation in Huntington's chorea.
    Müller EE; Parati EA; Panerai AE; Cocchi D; Caraceni T
    Neuroendocrinology; 1979; 28(5):313-9. PubMed ID: 155781
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Plasma homovanillic acid and prolactin in Huntington's disease.
    Markianos M; Panas M; Kalfakis N; Vassilopoulos D
    Neurochem Res; 2009 May; 34(5):917-22. PubMed ID: 18841471
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Altered growth hormone release in Huntington's chorea.
    Keogh HJ; Johnson RH; Nanda RN; Sulaiman WR
    J Neurol Neurosurg Psychiatry; 1976 Mar; 39(3):244-8. PubMed ID: 132511
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bromocriptine in the medical management of acromegaly.
    Besser GM; Wass JA; Thorner MO
    Adv Biochem Psychopharmacol; 1980; 23():191-8. PubMed ID: 6249090
    [No Abstract]   [Full Text] [Related]  

  • 39. A giant prolactinoma and the effect of chronic bromocriptine therapy on basal and TRH-stimulated serum prolactin levels.
    Barrera CM; Ruiz AE; Banks WA
    Horm Res; 1991; 35(3-4):167-9. PubMed ID: 1806471
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Effect of CB-154 in acromegaly].
    Ishibashi M; Yamaji T
    Horumon To Rinsho; 1977 Dec; 25(12):1292-6. PubMed ID: 598022
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.